Status:
COMPLETED
Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2
Lead Sponsor:
NVP Healthcare
Conditions:
Healthy
Eligibility:
All Genders
19+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2.
Detailed Description
pharmacokinetics and safety of NVP-1805 compared to coadministration of NVP-1805-R1 with NVP-1805-R2
Eligibility Criteria
Inclusion
- Healthy adult subjects who signed informed consent
- BMI of \>18.0 kg/㎡ and \<30.0 kg/㎡ subject, weight more than 50kg(45 kg or more for woman)
Exclusion
- Subjects participated in another clinical trial within 6 months prior to administration of the study drug
- Inadequate subject for the clinical trial by the investigator's decision
- Subjects participated in another clinical trial within 6 months prior to administration of the study drug
Key Trial Info
Start Date :
August 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 16 2021
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04780386
Start Date
August 29 2020
End Date
February 16 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H Plus Yangji Hospital
Seoul, Nambusunhwan-ro, South Korea, 08779